Plain-English translation of NCT07352332 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is observing how a new treatment called CD3×CD19 BiTE affects the immune system in children with severe lupus that hasn't improved with standard medications. Researchers will collect blood samples over time to study changes in immune cells and understand how this therapy works. You won't be starting the treatment just for this study—you'll only be included if you're already receiving it as part of your regular clinical care.
Children with severe lupus sometimes don't get better even after trying many standard treatments. Doctors have seen that this medication seems to help, but they don't yet understand exactly how it changes the immune system or which patients benefit most. This study aims to map out those immune changes so doctors can better predict who will respond well and how to improve care.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn at set times before and after you start (or have started) the medication as part of your regular clinic visits. These samples will be sent to the lab for special testing that examines different types of immune cells and how they change over time. The study runs alongside your regular medical care—researchers are simply collecting and studying blood that's already being taken as part of monitoring your lupus.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China